Back to Search
Start Over
Expression of prostaglandin PGE2 receptors under conditions of aging and stress and the protective effect of the EP2 agonist butaprost on retinal ischemia.
- Source :
-
Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2009 Jul; Vol. 50 (7), pp. 3238-48. Date of Electronic Publication: 2009 Mar 05. - Publication Year :
- 2009
-
Abstract
- Purpose: To localize different prostaglandin E(2) receptors in rat retinas of varying age, deduce how they are affected by acute stress insult, and determine whether the negative effect of ischemia/reperfusion is attenuated by the EP2 agonist butaprost.<br />Methods: Ischemia was induced by the elevation of intraocular pressure. Butaprost was injected intravitreally immediately after ischemia. Standard methods were used for recording of electroretinograms (ERGs) and processing of immunohistochemistry. Extracts of whole retinas were analyzed for specific proteins by Western blotting or by RT-PCR for defined mRNAs.<br />Results: The localization of different EP receptor types is similar in retinas of all aged rats. However, differences exist in the monomer/dimer ratios in retinas of different age. Acute stress insult (48 hours after ischemia) affects the ratio of monomer/dimer of all EP receptor types and increases EP2 and EP3 immunoreactivities in Müller cells of the adult retina. Ischemia and 5 to 7 days of reperfusion to the retina caused the normal ERG and the localization of nNOS and ChAT immunoreactivities to be affected. Certain proteins and mRNAs were lowered in content, whereas other proteins and mRNAs were upregulated. In addition, specific optic nerve proteins were drastically reduced. Most of these changes induced by ischemia/reperfusion were significantly blunted by butaprost.<br />Conclusions: All subtypes of EP receptors exist primarily in the inner retina at different ages, but their monomer/dimer ratios vary. Stress affects the monomer/dimer ratio and EP2 and EP3 immunoreactivities in Müller cells. Butaprost injected intravitreally significantly blunts the detrimental influence of ischemia/reperfusion to the retina.
- Subjects :
- Alprostadil therapeutic use
Animals
Blotting, Western
DNA Primers chemistry
Electroretinography
Immunohistochemistry
Injections
Nerve Tissue Proteins genetics
Nitric Oxide Synthase Type I metabolism
Prostaglandins E, Synthetic therapeutic use
RNA, Messenger metabolism
Rats
Rats, Wistar
Receptors, Prostaglandin E agonists
Receptors, Prostaglandin E, EP2 Subtype
Reperfusion Injury metabolism
Reperfusion Injury physiopathology
Retina metabolism
Retina physiopathology
Retinal Diseases metabolism
Retinal Diseases physiopathology
Reverse Transcriptase Polymerase Chain Reaction
Vitreous Body
Aging physiology
Alprostadil analogs & derivatives
Oxidative Stress
Receptors, Prostaglandin E metabolism
Reperfusion Injury prevention & control
Retinal Diseases prevention & control
Subjects
Details
- Language :
- English
- ISSN :
- 1552-5783
- Volume :
- 50
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Investigative ophthalmology & visual science
- Publication Type :
- Academic Journal
- Accession number :
- 19264896
- Full Text :
- https://doi.org/10.1167/iovs.08-3185